Top Markets
#1 Black Phoenix Black Phoenix +21,482.50%
#2 Nesa Nesa +735.74%
#3 Kinesis Silver Kinesis Silver +55.32%
#4 BNB Attestation Service BNB Attestation Service +23.46%
#5 QuantixAI QuantixAI +23.11%
#6 EXOD EXOD +22.78%
#7 Derive Derive +20.24%
#8 Magma Finance Magma Finance +19.23%
#9 Biconomy Biconomy +18.17%
#10 Zylo Ecosystem Zylo Ecosystem +16.40%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Kedudukan dalam Saham #19063
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Harga Saham
$1.27
Modal Pasaran
$176.31M
Perubahan (1 hari)
5.57%
Perubahan (1 tahun)
29.36%
Negara
TW
Perdagangan Medigen Biotechnology Corp. (3176)

Kategori

Healthcare
Pendapatan untuk Medigen Biotechnology Corp. (3176)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Medigen Biotechnology Corp., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Medigen Biotechnology Corp. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH